This site is intended for Healthcare Professionals only

Drug safety update: hyoscine butylbromide injection

Pharmacy News bookmark icon off

Drug safety update: hyoscine butylbromide injection

The MHRA has issued the following Drug Safety Update for hyoscine butylbromide (Buscopan) injection: risk of serious adverse effects in patients with underlying cardiac disease.

Prescribing information has been updated to help to minimise the risk of serious adverse reactions in patients with cardiac disease. More information here.

 

Copy Link copy link button

Pharmacy News

Stay up to date with all the news, learning and insight in the world of pharmacy.

Share: